BIOEQUIVALENCE BETWEEN INNOVATOR AND GENERIC TACROLIMUS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED, CROSSOVER CLINICAL TRIAL.

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.

BACKGROUND:Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients.Several professional transplant societies and publications have generated skepticism of the generic approval process.Three ma

read more

Racial Disparities in Service Use among Medicaid Beneficiaries after Mandatory Enrollment in Managed Care: A Difference-in-Differences Approach

Managed care may improve access to health care to previously underserved populations when providers need plan enrollees.However, capitation and utilization management often give providers the incentive to withhold care.Managed care organizations have yet to demonstrate Waste/Litter that racial disparities in treatment are not exacerbated.Using Medi

read more